1346576-23-5

Basic information

• Product Name: tert-butyl ((6-benzyl-4-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamate
• Synonyms: tert-butyl ((6-benzyl-4-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamate
• CAS NO: 1346576-23-5
• Molecular Weight: 328.411
• Mol File: 1346576-23-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl ((6-benzyl-4-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl ((6-benzyl-4-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamate(1346576-23-5)
• EPA Substance Registry System: tert-butyl ((6-benzyl-4-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamate(1346576-23-5)

Safety Data

• Hazardous Substances Data: 1346576-23-5(Hazardous Substances Data)

Upstream product

• 101-97-3 Ethyl 2-phenylethanoate 
• 1346576-20-2 4-methyl-2-oxo-6-(phenylmethyl)-1,2-dihydro-3-pyridinecarbonitrile 
• 3318-61-4 1-phenyl-2,4-pentanedione 
• 1346576-21-3 3-(aminomethyl)-6-methyl-4-(phenylmethyl)-2(1H)-pyridinone 
• 1346576-22-4 3-(aminomethyl)-4-methyl-6-(phenylmethyl)-2(1H)-pyridinone 
• 24424-99-5 di-tert-butyl dicarbonate 
• 107-91-5 cyanoacetic acid amide 

Downstream Products

• 1346576-18-8 3-(aminomethyl)-4-methyl-6-(phenylmethyl)-2(1H)-pyridinone hydrochloride 

Relevant articles and documents

METHOD OF TREATMENT

The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.

ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS

This invention relates to novel substituted benzamide according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.